Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Shiping Fu"'
Autor:
Chongben Tao, Shiping Fu, Chen Wang, Xizhao Luo, Huayi Li, Zhen Gao, Zufeng Zhang, Sifa Zheng
Publikováno v:
IEEE Internet of Things Journal. 10:8031-8045
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20d6fe8ebc3f69de3630b399de42133f
https://doi.org/10.1109/jiot.2022.3231369
https://doi.org/10.1109/jiot.2022.3231369
Publikováno v:
International Journal of Biological Macromolecules. 117:102-107
One homogeneous polysaccharide (ZWP) was successfully isolated and purified from the rhizomes of Curcuma zedoaria and the aim of present study was to determine the potential of chitosan/silk hydrogel sponge loaded with platelet-rich plasma exosomes (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08924b1128584c5dd6c63f0c19ffdd6c
https://doi.org/10.1016/j.ijbiomac.2018.05.066
https://doi.org/10.1016/j.ijbiomac.2018.05.066
Publikováno v:
Pathology & Oncology Research. 25:875-881
AT-rich interactive domain-containing protein 1A (ARID1A) has been shown to function as a tumour suppressor in various malignancies. However, the biological role of ARID1A in osteosarcoma is not clear. The present study aimed to investigate the expre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eb68ffd1b25196afea0269d4f5d4c53
https://doi.org/10.1007/s12253-017-0338-8
https://doi.org/10.1007/s12253-017-0338-8
Resveratrol is cytotoxic and acts synergistically with NF-κB inhibition in osteosarcoma MG-63 cells.
Publikováno v:
Archives of Medical Science; 2021, Vol. 17 Issue 1, p166-176, 11p
Publikováno v:
Archives of Medical Science : AMS
IntroductionOsteosarcoma is the most common primary malignancy of the bone. The existing adjuvant chemotherapy regimens, while improving the overall survival, have been limited by the significant systemic toxicity. Substantial clinical and research e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fd17692d06be356dbebb7d76b76ee03
https://pubmed.ncbi.nlm.nih.gov/33488869
https://pubmed.ncbi.nlm.nih.gov/33488869
Publikováno v:
Experimental and Therapeutic Medicine
The present study formulated a hydroxyapatite (HA)-coated lipid nanoparticle loaded with zoledronic acid to treat patients with osteoporosis (OP). HA-coated zoledronic acid loaded lipid bilayer nanoparticles (HZL NPs) were prepared using methods of e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e404ce3dff149f78c80a3ceead566daf
https://pubmed.ncbi.nlm.nih.gov/30116324
https://pubmed.ncbi.nlm.nih.gov/30116324
Publikováno v:
Journal of cellular biochemistry. 118(12)
The aim of this study was to determine the relationship between serum fibroblast growth factor-23 (FGF-23) level and bone mass in postmenopausal women. A total of 60 premenopausal, 60 early postmenopausal, and 60 late postmenopausal women were invest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd64978fe15d0daf582174ce6ccf91ae
https://pubmed.ncbi.nlm.nih.gov/28464278
https://pubmed.ncbi.nlm.nih.gov/28464278
Publikováno v:
Molecular and Cellular Biochemistry. 381:9-15
MicroRNA-132 (miR-132), an angiogenic growth factor inducible microRNA in the endothelium, facilitates pathological angiogenesis. Previous study showed that miR-132 was downregulated in human osteosarcoma. However, its functional attributes associate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f6c7ffa63b42b0f2a2ce36780c8daa7
https://doi.org/10.1007/s11010-013-1677-8
https://doi.org/10.1007/s11010-013-1677-8
Publikováno v:
Pathology, research and practice. 213(3)
MicroRNA (miR)-19a, a member of the miR-17-92 cluster, functions as an oncomiRNA in multiple kinds of cancers. However, its involvement in human osteosarcomas remains unclear. In this study, to analyze the expression pattern of miR-19a and to investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f5e4b1d92f90d5ddf0e040c7f284474
https://pubmed.ncbi.nlm.nih.gov/28214202
https://pubmed.ncbi.nlm.nih.gov/28214202